Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors

Guillaume Becker, Julie Colomb, Thierry Billard and Luc Zimmer
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 326;
Guillaume Becker
2CERMEP-Imaging Platform, Hospices Civils de Lyon, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Colomb
3Institute of Chemistry and Biochemistry, University of Lyon & CNRS, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry Billard
3Institute of Chemistry and Biochemistry, University of Lyon & CNRS, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luc Zimmer
1Lyon Neuroscience Research Center, University Hospital of Lyon & CNRS & INSERM, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 326

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Guillaume Becker2,
  2. Julie Colomb3,
  3. Thierry Billard3 and
  4. Luc Zimmer1
  1. 1Lyon Neuroscience Research Center, University Hospital of Lyon & CNRS & INSERM, Lyon, France
  2. 2CERMEP-Imaging Platform, Hospices Civils de Lyon, Lyon, France
  3. 3Institute of Chemistry and Biochemistry, University of Lyon & CNRS, Lyon, France

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: February 2015 to April 2025

AbstractFullPdf
Feb 2015300
Mar 2015400
May 2015100
Jul 2015400
Sep 2015600
Mar 2016100
Apr 2016100
May 2016100
Aug 2016200
Oct 2016500
Nov 2016300
Dec 2016100
Jan 20175000
Mar 20172000
Apr 2017100
May 2017100
Jun 2017100
Jul 2017300
Aug 2017200
Sep 2017100
Oct 2017100
Nov 2017200
Feb 2018100
Apr 2018100
Oct 2018100
Feb 2019100
Jan 2020100
Feb 2020100
Mar 2020100
Jul 2020100
Aug 2020100
Sep 2020200
Oct 2020100
Dec 2020100
Jan 2021200
Feb 2021600
Mar 2021500
Apr 2021600
May 2021400
Jun 2021200
Jul 2021500
Aug 2021300
Sep 2021300
Oct 2021200
Nov 2021200
Dec 2021100
Jan 2022200
Feb 2022400
Mar 2022100
Apr 2022100
May 2022300
Jun 2022300
Aug 2022100
Sep 2022400
Oct 2022100
Jan 2023200
Mar 2023100
Apr 2023200
May 2023200
Jun 2023100
Jul 2023200
Aug 2023200
Sep 2023100
Oct 2023300
Nov 2023100
Dec 2023200
Jan 2024400
Mar 2024300
Apr 2024100
May 2024200
Jun 2024200
Jul 20244200
Aug 20244500
Sep 2024200
Oct 2024300
Nov 2024500
Dec 2024500
Feb 2025300
Mar 2025100
Apr 2025500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors
Guillaume Becker, Julie Colomb, Thierry Billard, Luc Zimmer
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 326;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiosynthesis and radiopharmacological evaluation of fluorinated PET radioligands for the 5-HT6 receptors
Guillaume Becker, Julie Colomb, Thierry Billard, Luc Zimmer
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 326;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • Inflammation imaging using a 99mTc-labeled neutrophil-targeting peptide
  • PET imaging and quantification of the effects of succinylated gelatin and/or L-lysine on renal uptake and retention of the novel radiopharmaceutical 64Cu-cyclam-RAFT-c(-RGDfK-)4
  • Baculovirus as an ideal radionuclide reporter gene vector: A new strategy for monitoring the fate of human stem cell in vivo
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Preclinical Probes for Neuroimaging Oral I

  • A novel high affinity F-18 organophosphonate tracer for CNS acetylcholinesterase
  • 3-[123I]Iodo-5-(pyridine-2-ylethynyl)benzonitrile ([123I]IPEB): A new SPECT ligand for metabotropic glutamate receptor subtype 5 (mGluR5)
  • Radiosynthesis and preliminary in vivo studies with [11C]SB216763: The first brain penetrative PET tracer for imaging of glycogen synthase kinase-3 (GSK-3)
Show more Preclinical Probes for Neuroimaging Oral I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire